Lipidomic profiling before and after Roux-en-Y gastric bypass in obese patients with diabetes

Pharmacogenomics Journal

Volumn 14, Issue 3, 2014, Pages 201-207

  Graessler, J ^a   Bornstein, T D ^a   Goel, D ^b   Bhalla, V P ^b   Lohmann, T ^c   Wolf, T ^c   Koch, M ^a   Qin, Y ^d   Licinio, J ^e   Wong, M L ^e   Chavakis, T ^a   Xu, A ^f   Shevchenko, A ^g   Schuhmann, K ^a,g   Schwarz, P E H ^a   Schulte, K M ^h   Patel, A ^h   Bornstein, S R ^a,i  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b Department of Minimal Access Bariatric and Surgical Gastroenterology BLK Super Speciality Hospital ^*  (India)

^c Dresden Interdisciplinary Adiposity Center   (Germany)

^d BGI SHENZHEN   (China)

^e Australian National University   (Australia)

^f UNIVERSITY OF HONG KONG   (Hong Kong)

^g MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

^h KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

gastric bypass; lipidomics; plasma lipidomic profile; type 2 diabetes mellitus

Indexed keywords

CERAMIDE; CHOLESTEROL; CHOLESTEROL ESTER; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE ETHER; PHOSPHATIDYLINOSITOL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; HUMAN; LIPID METABOLISM; LIPIDOMICS; MALE; MORBID OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; STOMACH BYPASS; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CLASSIFICATION; COMPLICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY, MORBID;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 2; GASTRIC BYPASS; HUMANS; LIPIDS; OBESITY, MORBID;

EID: 84901272077     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/tpj.2013.42     Document Type: Article

References (36)

1. Cohen R, Caravatto PP, Petry T, Cummings D. Role of metabolic surgery in less obese or non-obese subjects with type 2 diabetes: influence over cardiovascular events. Curr Atheroscler Rep 2013; 15: 355.
2. Vidal J, Jimenez A. Diabetes remission following metabolic surgery: is glp-1 the culprit? Curr Atheroscler Rep, 2013; 15: 357.
3. Huang H, Kasumov T, Gatmaitan P, Heneghan HM, Kashyap SR, Schauer PR et al. Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients. Obesity (Silver Spring) 2011; 19: 2235-2240.
4. Simonen M, Dali-Youcef N, Kaminska D, Venesmaa S, Kakela P, Paakkonen M et al. Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass. Obes Surg 2012; 22: 1473-1480.
5. Heneghan HM, Huang H, Kashyap SR, Gornik HL, McCullough AJ, Schauer PR et al. Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio. Surg Obes Relat Dis 2013; 9: 100-107.
6. Stemmer K, Bielohuby M, Grayson BE, Begg DP, Chambers AP, Neff C et al. Rouxen- Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats. Endocrinology 2013; 154: 2015-2024.
7. Kosinska MK, Liebisch G, Lochnit G, Wilhelm J, Klein H, Kaesser U et al. A Lipidomic study of phospholipid classes and species in human synovial fluid. Arthritis Rheum 2013; 65: 2323-2333.
8. To VT, Huttl TP, Lang R, Piotrowski K, Parhofer KG. Changes in body weight, glucose homeostasis, lipid profiles, and metabolic syndrome after restrictive bariatric surgery. Exp Clin Endocrinol Diabetes 2012; 120: 547-552.
9. Graessler J, Schwudke D, Schwarz PE, Herzog R, Shevchenko A, Bornstein SR. Topdown lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. PLoS One 2009; 4: e6261.
10. Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A, Schwudke D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res 2008; 49: 1137-1146.
11. Schuhmann K, Almeida R, Baumert M, Herzog R, Bornstein SR, Shevchenko A. Shotgun lipidomics on a LTQ Orbitrap mass spectrometer by successive switching between acquisition polarity modes. J Mass Spectrom 2012; 47: 96-104.
12. Herzog R, Schwudke D, Schuhmann K, Sampaio JL, Bornstein SR, Schroeder M et al. A novel informatics concept for high-throughput shotgun lipidomics based on the molecular fragmentation query language. Genome Biol 2011; 12: R8.
13. Dirksen C, Jorgensen NB, Bojsen-Moller KN, Jacobsen SH, Hansen DL, Worm D et al. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabetologia 2012; 55: 1890-1901.
14. Lima MM, Pareja JC, Alegre SM, Geloneze SR, Kahn SE, Astiarraga BD et al. Acute effect of roux-en-y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab 2010; 95: 3871-3875.
15. Despres JP. Cardiovascular disease under the influence of excess visceral fat. Crit Pathw Cardiol 2007; 6: 51-59.
16. Vix M, Diana M, Liu KH, D'Urso A, Mutter D, Wu HS et al. Evolution of glycolipid profile after sleeve gastrectomy vs. Roux-en-Y gastric bypass: results of a prospective randomized clinical trial. Obes Surg 2013; 23: 613-621.
17. Li Q, Chen L, Yang Z, Ye Z, Huang Y, He M et al. Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass indexo35 kg/m2. Diabetes Obes Metab 2013; 14: 262-270.
18. Raffaelli M, Guidone C, Callari C, Iaconelli A, Bellantone R, Mingrone G. Effect of gastric bypass versus diet on cardiovascular risk factors. Ann Surg 2013; 1-6; doi:10.1097/SLA.0b013e31829d6989 (e-pub ahead of print).
19. Pietilainen KH, Sysi-Aho M, Rissanen A, Seppanen-Laakso T, Yki-Jarvinen H, Kaprio J et al. Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects - a monozygotic twin study. PLoS One 2007; 2: e218.
20. Zhao X, Fritsche J, Wang J, Chen J, Rittig K, Schmitt-Kopplin P et al. Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits. Metabolomics 2010; 6: 362-374.
21. Huo T, Cai S, Lu X, Sha Y, Yu M, Li F. Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride. J Pharm Biomed Anal 2009; 49: 976-982.
22. Han MS, Lim YM, Quan W, Kim JR, Chung KW, Kang M et al. Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance. J Lipid Res 2011; 52: 1234-1246.
23. Heilbronn LK, Coster AC, Campbell LV, Greenfield JR, Lange K, Christopher MJ et al. The effect of short-term overfeeding on serum lipids in healthy humans. Obesity (Silver Spring) 2013; 21: E649-E659.
24. Barber MN, Risis S, Yang C, Meikle PJ, Staples M, Febbraio MA et al. Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS One 2012; 7: e41456.
25. Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, Liu Y et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesityinduced insulin resistance. Cell Metab 2007; 5: 167-179.
26. Meikle PJ, Wong G, Barlow CK, Weir JM, Greeve MA, Macintosh GL et al. Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLoS One 2013; 8: e74341.
27. Maris M, Robert S, Waelkens E, Derua R, Hernangomez MH, D'Hertog W et al. Role of the saturated nonesterified fatty acid palmitate in beta cell dysfunction. J Proteome Res 2013; 12: 347-362.
28. Mayneris-Perxachs J, Guerendiain M, Castellote AI, Estruch R, Covas MI, Fito M et al. Plasma fatty acid composition, estimated desaturase activities, and their relation with the metabolic syndrome in a population at high risk of cardiovascular disease. PLoS One 2013; 8: e74341.
29. Mahendran Y, Cederberg H, Vangipurapu J, Kangas AJ, Soininen P, Kuusisto J et al. Glycerol and Fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in finnish men. Diabetes Care 2013; 36: 3732-3738.
30. Warensjo E, Riserus U, Vessby B. Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 2005; 48: 1999-2005.
31. Virtanen JK, Mursu J, Voutilainen S, Uusitupa M, Tuomainen TP. Serum omega-3 polyunsaturated fatty acids and risk of incident type 2 diabetes in men: the kuopio ischaemic heart disease risk factor study. Diabetes Care 2013; doi:10.2337/ dc13-1504 (e-pub ahead of print).
32. Bojsen-Moller KN, Dirksen C, Jorgensen NB, Jacobsen SH, Hansen DL, Worm D et al. Increased hepatic insulin clearance after Roux-en-Y gastric bypass. J Clin Endocrinol Metab 2013; 98: E1066-E1071.
33. Immonen H, Hannukainen JC, Iozzo P, Soinio M, Salminen P, Lepomaki V et al. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients. J Hepatol 2013; doi:10.1016/j.jhep.2013.09. 012 (e-pub ahead of print).
34. van der Veen JN, Lingrell S, Vance DE. The membrane lipid phosphatidylcholine is an unexpected source of triacylglycerol in the liver. J Biol Chem 2012; 287: 23418-23426.
35. Graessler J, Qin Y, Zhong H, Zhang J, Licinio J, Wong ML et al. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics J 2013; 13: 514-522.
36. Vareka T, Vecka M, Jirak R, Tvrzicka E, Macasek J, Zak A et al. Plasma fatty acid profile in depressive disorder resembles insulin resistance state. Neuro Endocrinol Lett 2012; 33(Suppl 2): 83-86.